Compare Abeona Therapeutics Inc (ABEO) vs Vanguard Total International Bond Index Fund ETF (BNDX) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs Vanguard Total International Bond Index Fund ETF — how do they compare? Abeona Therapeutics Inc trades at $6.74 (market cap $373.32M), while Vanguard Total International Bond Index Fund ETF trades at $47.83. The key difference: Abeona Therapeutics Inc is trading nearer its 52-week high, Vanguard Total International Bond Index Fund ETF nearer its low. Which is the better fit depends on your goals.
| ABEO | BNDX | |
|---|---|---|
Market Cap | $373.32M | — |
Sector | Health | — |
52-Week High | $7.23 | $49.91 |
52-Week Low | $4.17 | $47.57 |
Enterprise Value | $228.22M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
BNDX is trading at $48.02, down 0.46% on the day, with technical indicators showing a bearish trend as moving averages signal selling pressure. The ETF maintains consistent dividend distributions of $0.11 per share scheduled through mid-2026. Current market sentiment reflects uncertainty around Federal Reserve policy direction, with bond ETF flows showing increased investor interest in fixed income amid stock market volatility.
The outlook for BNDX remains tied to interest rate expectations and bond market dynamics. While the ETF offers income stability through regular dividends, potential Fed rate hikes could pressure bond prices. Investors seeking reliable income may find value, but should monitor monetary policy developments closely given the current bearish technical setup.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Vanguard Total International Bond Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the Bloomberg Global Aggregate ex-USD Float Adjusted RIC Capped Index (USD Hedged). This index provides a broad-based measure of the global, investment-grade, fixed-rate debt markets. It is non-diversified.
Read more on BNDX →
